ANTI-PLAQUE INGREDIENT REVIEW BY FDA'S PLAQUE SUBCOMMITTEE
This article was originally published in The Rose Sheet
Executive Summary
ANTI-PLAQUE INGREDIENT REVIEW BY FDA'S PLAQUE SUBCOMMITTEE initially will include 12 single ingredients and four combinations, OTC Plaque Products Subcommittee Acting Chair Robert Genco, DDS/PhD, State University of New York School of Medicine, reported at a June 28-29 meeting. The subcommittee is charged with reviewing the safety and efficacy and risk/benefit of anti-plaque ingredients ("The Rose Sheet" Aug. 9, 1993, p. 1). Genco said the committee plans to review single ingredients when used in combination products at a later date.